Antibody engineers seek optimal drug targeting TIGIT checkpoint
- Nat Biotechnol. 2020 Sep;38(9):1007-1009. doi: 10.1038/s41587-020-0666-1.
Affiliations
- 1. , Somerville, MA, USA.
PMID: 32887966
DOI: 10.1038/s41587-020-0666-1
Products
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Transmembrane GlycoproteinResearch Areas: Cancer